Regulatory Filing & Pre- License/Pre-Approval Inspections of ...

More documents

Recommendations

Info

Pre-License & Pre-ApprovalInspections‣Conducted by CDER reviewers in DMPQ/BMTand OBP/DMA or OBP/DTP with BMT as thelead‣District invited to participate (domesticinspections)‣PLIs and PAIs are announced‣Biennial (or surveillance) inspections areconducted after approval typically by ORA26
Inspection StrategySystems-based‣Quality System‣Facilities and Equipment‣Production System‣Materials‣Laboratory Controls‣Packaging and Labeling27
Page 1 and 2: Regulatory Filing & Pre-License/Pre
Page 3 and 4: Regulatory Authority3
Page 6: 21 CFR Part 601 - LicensingRelevant
Page 9 and 10: “Specified” Biological Products
Page 11 and 12: 21 CFR 601.20 - Biologics licenses;
Page 13 and 14: Organization13
Page 16 and 17: Division of Manufacturing and Produ
Page 18 and 19: BMT Review of a BLADrug Substance
Page 20: BMT Review of a BLADrug Product (co
Page 23 and 24: Review Issues‣ Bulk thaw & hold l
Page 25: Purpose of Inspection‣Meet statut
Page 29 and 30: Inspection Outcome & Approval‣A r
Page 31 and 32: Quality Oversight‣Inadequate qual
Page 33 and 34: SOPs‣ SOPs are not executed consi
Page 35 and 36: Utilities‣High bioburden counts f
Page 37 and 38: Production‣Discrepancies between
Page 39 and 40: Laboratory‣Assays not appropriate
Page 41 and 42: Additional Information/Resources‣
Page 43: Contact InformationAnastasia Lolas3

Regulatory Filing & Pre- License/Pre-Approval Inspections of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?